11-5225486-T-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 3P and 1B. PM2PP5BP4
The ENST00000335295.4(HBB):c.*112A>G variant causes a 3 prime UTR change. The variant allele was found at a frequency of 0.00000116 in 859,910 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (no stars).
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000012 ( 0 hom. )
Consequence
HBB
ENST00000335295.4 3_prime_UTR
ENST00000335295.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.64
Genes affected
HBB (HGNC:4827): (hemoglobin subunit beta) The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 11-5225486-T-C is Pathogenic according to our data. Variant chr11-5225486-T-C is described in ClinVar as [Pathogenic]. Clinvar id is 15476.Status of the report is no_assertion_criteria_provided, 0 stars. Variant chr11-5225486-T-C is described in Lovd as [Pathogenic].
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.38). . Strength limited to SUPPORTING due to the PP5.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HBB | NM_000518.5 | c.*112A>G | 3_prime_UTR_variant | 3/3 | ENST00000335295.4 | NP_000509.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HBB | ENST00000335295.4 | c.*112A>G | 3_prime_UTR_variant | 3/3 | 1 | NM_000518.5 | ENSP00000333994 | P1 | ||
HBB | ENST00000647020.1 | c.*112A>G | 3_prime_UTR_variant | 3/3 | ENSP00000494175 | P1 | ||||
HBB | ENST00000633227.1 | c.*372A>G | 3_prime_UTR_variant, NMD_transcript_variant | 3/3 | 3 | ENSP00000488004 | ||||
ENST00000644706.1 | upstream_gene_variant |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome AF: 0.00000116 AC: 1AN: 859910Hom.: 0 Cov.: 12 AF XY: 0.00000221 AC XY: 1AN XY: 451864
GnomAD4 exome
AF:
AC:
1
AN:
859910
Hom.:
Cov.:
12
AF XY:
AC XY:
1
AN XY:
451864
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Asia WGS
AF:
AC:
3
AN:
3478
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Beta-plus-thalassemia Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 20, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at